Picard Medical to Present the Next Generation Fully Implantable SynCardia Total Artificial Heart at ISMCS 2025

Core Viewpoint - Picard Medical, Inc. will present in vitro data on its fully implantable Emperor Total Artificial Heart at the ISMCS 2025 conference, highlighting advancements in patient mobility and quality of life [1][3]. Group 1: Presentation Details - The presentation is scheduled for December 4, 2025, at 14:05 CET during the Mini Oral Session 3 focused on Hemocompatibility and Heart/Pump Interaction [2]. - The title of the presentation is "The Emperor Total Artificial Heart: A Next Generation, Fully Implantable Total Artificial Heart," and it will be presented by Duffy Elmer, Engineering Project Manager at Picard Medical [2]. Group 2: Product Information - The Emperor Total Artificial Heart features an internal motor-driven design that eliminates the need for an external pneumatic driver, aiming to enhance patient mobility and overall quality of life [3]. - Picard Medical, through its subsidiary SynCardia Systems, is the only company with commercially available total artificial heart technology for patients with end-stage heart failure, having performed over 2,100 implants across 27 countries [5]. Group 3: Event Information - ISMCS 2025 is the 31st annual global congress of the International Society for Mechanical Circulatory Support, bringing together various stakeholders to discuss new clinical research and emerging technologies in mechanical circulatory support [4].